AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DEXAMETHASONE SODIUM

8 registrations across 5 African markets— 5 active

Markets with DEXAMETHASONE SODIUM

Recent registrations

Brand / ProductMarketHolderStatusExpires
DEXAMETHASONE 4MG/ML INJECTION
INJECTION
🇲🇼MalawiexpiredMar 2024
DEXAMETHASONE_SODIUM 0.1% EYE SOLUTION
EYE SOLUTION
🇲🇼MalawiexpiredMar 2024
EVERDESTINY DEXAMETHASO NE SODIUM PHOSPHATE INJECTION
INJECTION/ 1ML X 10AMPOULES
🇳🇬NigeriaEVERDESTINY PHARM. LIMITED. 20expiredMar 2022
Ivydexone eye drops
Eye Drops
🇹🇿TanzaniaB. Braun Pharmaceuticals EPZ Ltdactive
DEXAMETHASONE SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaSAKAR HEALTH CARE PVT .LTDactive
DEXAMETHASONE SODIUM
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaSAKAR HEALTH CARE PVT .LTDactive
INO-DEXASON 4MG/ML SI IM/IV BTE(10AMP X 1ML) NINGBO INOPHA
Solution injectable IM/IV,boîte
🇲🇬MadagascarNINGBO INOPHA BIOTEC LTD F11active
INO-DEXASON 4MG/ML SI IM/IV BTE(10AMP X 1ML) NINGBO INOPHA
Solution injectable IM/IV,boîte
🇲🇬MadagascarNINGBO INOPHA BIOTEC LTD F11active

DEXAMETHASONE SODIUM in Africa — Regulatory Overview

DEXAMETHASONE SODIUM is registered across 5 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Malawi, Uganda, Nigeria and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.